Posted by Michael Wonder on 07 Dec 2022
An innovation surcharge to fund the repurposing of generic drugs
10 November 2022 - The use of generic drugs continues to increase, generating substantial savings for purchasers and improving affordable access for patients.
However, the expansion of generic drug use has come at the cost of a progressive narrowing of the financial basis for pharmaceutical innovation.
